Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | BCL2 | P10415 | 1/20 | 0.40 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 2/20 | 0.38 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL646951 | 0.87 | ALDH1A1 (0.43) | CYP1A2IDO1ALDH1A1MAPTLMNA | |
| SCHEMBL166894 | 0.87 | TP53 (0.61) | TP53CYP1A2CYP2A6MGLLBCL2 | |
| Benzene SCHEMBL9785236 | 0.84 | TP53 (0.67) | TP53CYP1A2CYP2A6MGLLBCL2 | |
| Ammonia Solution, Strong SCHEMBL28805948 | 0.84 | TP53 (0.58) | TP53CYP1A2CYP2A6MGLLBCL2 | |
| SCHEMBL28256639 | 0.84 | TP53 (0.58) | TP53CYP1A2CYP2A6MGLLBCL2 | |
| Ethyne SCHEMBL28293458 | 0.81 | TP53 (0.55) | TP53CYP1A2CYP2A6MGLLBCL2 | |
| Ethylene SCHEMBL27256792 | 0.81 | TP53 (0.55) | TP53CYP1A2CYP2A6MGLLBCL2 | |
| Methyl Alcohol SCHEMBL28745884 | 0.81 | TP53 (0.55) | TP53CYP1A2CYP2A6MGLLBCL2 | |
| Hydrogen Peroxide SCHEMBL11520377 | 0.81 | TP53 (0.63) | TP53CYP1A2CYP2A6MGLLBCL2 | |
| SCHEMBL13313981 | 0.81 | CNR1 (0.42) | KIF11ALDH1A1SIGMAR1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111273-B2 | Cyclic peptides multimers targeting alpha-4-beta-7 integrin | ZEALAND PHARMA A/S (DK) | 2021-09-07 | — | — | US | disclosed |
| US-20210238141-A1 | COMPOUND, CURING AGENT COMPOSITION, RESIN COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-08-05 | — | — | US | disclosed |
| US-20200407521-A1 | POLYAMIDE-IMIDE FILM, PREPARATION METHOD THEREOF, AND DISPLAY FRONT PLATE AND DISPLAY DEVICE COMPRISING SAME | MICROWORKS SOLUTIONS CO., LTD. (KR) | 2020-12-31 | — | — | US | disclosed |
| US-20200216501-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ZEALAND PHARMA A/S (DK) | 2020-07-09 | — | — | US | disclosed |
| EP-3670529-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | Dong-A St Co., Ltd. (KR) | 2020-06-24 | — | — | EP | disclosed |
| US-9963605-B2 | Coloring composition, ink jet recording ink, and ink jet recording method | FUJIFILM CORPORATION (JP) | 2018-05-08 | — | — | US | disclosed |
| EP-2534152-B1 | MACROCYCLES AS FACTOR XIA INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-05-02 | — | — | EP | disclosed |
| US-20170210928-A1 | COLORING COMPOSITION, INK JET RECORDING INK, AND INK JET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170190928-A1 | COLORING COMPOSITION, INK JET RECORDING INK, AND INK JET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2017-07-06 | — | — | US | disclosed |
| EP-2099796-B1 | AZA-INDOLYL COMPOUNDS AND METHODS OF USE | GENENTECH INC (US) | 2011-06-01 | — | — | EP | disclosed |
| WO-2004100875-A2 | BENZIMIDAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | MERCK & CO., INC. (US) | 2004-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11111273-B2 | Cyclic peptides multimers targeting alpha-4-beta-7 integrin | ITGB7, ITGB4, ITGA4 | TP53 2926/4885CYP1A2 4768/4885CYP2A6 4483/4885 |
| US-20200216501-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ITGB7, ITGB4, ITGA4 | TP53 2926/4885CYP1A2 4768/4885CYP2A6 4483/4885 |
| US-20210238141-A1 | COMPOUND, CURING AGENT COMPOSITION, RESIN COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | CARM1, KDM2B, UFM1 | TP53 4499/4885CYP1A2 2226/4885CYP2A6 3446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.